NexGen Energy Ltd. (0V9D)
London Exchange · UK · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 11.91 |
|---|---|
| 52-week range | 10.36 – 18.78 |
| Return, 1 month / 3 months | −9.7% / −4.9% |
| Return, 1 year / 3 years | +0.6% / +51.1% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 60.7% |
| Worst drawdown (1 year) | -37.4% |
| Average daily value traded | 0.30M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NexGen Energy Ltd. is a uranium development company focused on advancing its Rook I project in the Athabasca Basin of Saskatchewan, Canada. The project centres on the Arrow deposit, a large uranium discovery that the company is developing toward production. NexGen's work covers exploration, engineering and permitting activities for the project. The company is based in Vancouver, Canada, and its activities serve the nuclear fuel market, where utilities and other buyers seek uranium for power generation.
On this site NexGen Energy Ltd. appears as a stock on the London Exchange (UK), code 0V9D, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NexGen Energy Ltd. (0V9D) trades on the London Exchange in UK. It last closed at CAD 11.91 on 19 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 3,065 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.6% and over the last three months it fell 4.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.6% | ||
| From 52-week high | -34.1% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.9% | ||
| 6-month return | -31.5% | ||
| 12-month return, skipping the last month | 11.5% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 60.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.4% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.30M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −5.7% |
|---|---|
| 1 month | −9.7% |
| 3 months | −4.9% |
| 6 months | −31.5% |
| 1 year | +0.6% |
| 3 years | +51.1% |
| 5 years | +57.1% |
Signals
| 50-day / 200-day average | 13.77 / 14.99 |
|---|---|
| Golden / death cross (60 days) | Death, 59 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.47 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.